Growth Metrics

Vera Therapeutics (VERA) Debt Ratio (2021 - 2023)

Vera Therapeutics posted quarterly Debt Ratio of 0.01 for Q1 2023, down 63.61% year-on-year from 0.04 in Q1 2022, and down 30.75% on a QoQ basis from 0.02 in Q4 2022.

Vera Therapeutics (VERA) has 3 years of Debt Ratio data on file, last reported at 0.01 in Q1 2023.

  • For the quarter ending Q1 2023, Debt Ratio fell 63.61% year-over-year to 0.01; the trailing twelve-month figure through Mar 2023 stood at 0.01 (down 63.61% YoY), and the FY2022 full-year result was 0.02, down 70.59% from the prior year.
  • Debt Ratio for Q1 2023 stood at 0.01, down from 0.02 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.07 in Q4 2021 and bottomed at 0.01 in Q3 2021.
  • The 3-year median for Debt Ratio is 0.04 (2022), against an average of 0.04.
  • Peak annual rise in Debt Ratio reached 319.18% in 2022, while the deepest fall reached 70.59% in 2022.
  • A 3-year view of Debt Ratio shows it stood at 0.07 in 2021, then sank by 70.59% to 0.02 in 2022, then sank by 30.75% to 0.01 in 2023.
  • The last three Debt Ratio figures came in at 0.01 (Q1 2023), 0.02 (Q4 2022), and 0.05 (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Vera Therapeutics 2.43 Bn 1.83 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 0.01
Dec 31, 2022 0.02
Sep 30, 2022 0.05
Jun 30, 2022 0.05
Mar 31, 2022 0.04
Dec 31, 2021 0.07
Sep 30, 2021 0.01